Bayer Reports Strong First-Half Sales in North America

Total first half sales in North America were EUR 4,393 million, an increase of 5.1 percent compared with first-half 2010 sales.

Bayer yesterday reported increased first-half 2011 sales in North America led by second-quarter gains in the company's CropScience subgroup. Total first half sales in the region were EUR 4,393 million ($6,158 million), an increase of 5.1 percent compared with first-half 2010 sales. Sales in the second quarter contributed to the overall first-half result by remaining strong at EUR 2,135 million ($2,993 million). This corresponds to an increase of 4.8 percent versus the second quarter 2010.

Bayer CropScience's sales in the second quarter increased by 19.2 percent to EUR 535 million ($750 million) and the subgroup's sales through the first-half of 2011 advanced by 21.3 percent to EUR 1,205 ($1,689 million).

Bayer HealthCare's sales in the second quarter declined by 1.2 per